-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - The clinical trials in head-neck cancer patients
were designed to improve outcomes by increasing tumor … trials and a Cochrane head-neck review) involving
non-anemic patients with head-neck cancer, a malignancy … Page 23, line 27:
This discussion focuses on hematologic malignancies. … Information on anemia
prevalence in non-myeloid malignancies could be included here. … This has been revised to include non-myeloid
malignancies.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
June 12, 2013 - “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR
carcinoma)) AND … OR ((ovarian OR breast OR colorectal
OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND
(‘neoplasm’/exp OR … ‘neoplasms’/exp OR ‘cancer’/exp OR ‘carcinoma’/exp)) AND
[humans]/lim AND [english]/lim AND [embase] … /lim
#60 #17 AND #59
#61 #56 AND #60
Ovarian Cancer
#61 ‘ovarian’/exp AND (‘neoplasm’/exp OR
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16813/prostate-cancer-models-overview/pdf
May 01, 2018 - treatment of screen-detected tumors. … We used the following keywords: prostate
cancer/neoplasms, PSA, mass screening, model, microsimulation … by CISNET as
“computer models that operate at the level of individuals or smaller entities such as tumors … on age, PSA, or stage/grade of tumor). … Prostate Cancer Group (SPCG-4) trial, which was not
conducted in men with screen-detected cancers.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - $ or tumor$ or malignan$ or carcino$ or neoplas$)).mp. … /ep, et
8 4 and 7
9 exp Breast Neoplasms/pc, eh
10 exp Breast Neoplasms/ge
A1-6
11 4 and … , urinary symptoms)
• Adverse breast outcomes (biopsies)
• Other malignancies (incidence, death)
• … in situ: data from the
Connecticut Tumor Registry. … Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan104/skin-cancer-screening-july-2016
July 17, 2014 - from skin cancer. … Key question 4 addresses whether skin cancer screening leads to earlier detection of skin cancer tumors … , specifically either an earlier stage tumor or one with less thickness. … Does visual screening for skin cancer lead to earlier detection of skin cancer compared with usual care … What is the association between earlier detection of skin cancer and skin cancer morbidity and mortality
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
October 07, 2011 - prostate cancers are localized 6 , 7 , 13 . … It did not specifically enroll men with screening-detected prostate cancer, and about 75% of cancers … Over three quarters of men with localized prostate cancer (about 90% of screening-detected cancers are … : HR, 1.8 (CI, 1.6–2.1)
Poorly differentiated tumors: HR, 1.1 (CI, 1.0–1.3)
4729/39,767 (rate … : HR, 1.2 (CI, 1.1–1.2)
Poorly differentiated tumors: HR, 1.0 (CI, 1.0–1.1)
Zhou et al,
-
psnet.ahrq.gov/node/60825/psn-pdf
August 19, 2020 - Effect of delays in the 2-week-wait cancer referral
pathway during the COVID-19 pandemic on cancer … Effect of delays in the 2-week-wait cancer referral pathway during the
COVID-19 pandemic on cancer survival … backlog in
cancer referrals on cancer survival. … proportion of patients with early-stage tumors progressing from having
curable to incurable disease … https://psnet.ahrq.gov/issue/effect-delays-2-week-wait-cancer-referral-pathway-during-covid-19-pandemic-cancer-survival-uk
-
www.uspreventiveservicestaskforce.org/Home/GetFile/1/16812/prostate-models-overdiagnosis/pdf
May 01, 2018 - by CISNET
as “computer models that operate at the level of individuals or smaller entities such as tumors … consists of tumor onset, time
from tumor onset to diagnosis (i.e., sojourn times), and sensitivity … 3 natural history states (healthy,
preclinical, clinical)
Does not specify stage or grade of
tumor … Sensitivity of screening test in an
increasing function of time since
tumor onset
Mechanism … Lifetime Risk of Overdiagnosis (Overdiagnosed Cancer as a Proportion of Screen-Detected Cancers) by Screening
-
psnet.ahrq.gov/issue/ethical-framework-allocating-scarce-life-saving-chemotherapy-and-supportive-care-drugs
September 07, 2016 - ethical framework for allocating scarce life-saving chemotherapy and supportive care drugs for childhood cancer … J Natl Cancer Inst. 2016;108(6):djv392. doi:10.1093/jnci/djv392. … guideline also provides clear reasoning for actual prioritization across and within common pediatric cancers … J Natl Cancer Inst. 2016;108(6):djv392. doi:10.1093/jnci/djv392. … November 1, 2016
Safety and diagnostic accuracy of tumor biopsies in children with cancer
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/skin-cancer-counseling-2003
October 06, 2003 - A large primary tumor (>2 cm) is associated with an increased risk of metastasis. … To find controlled trials of counseling (question 6), we searched MEDLINE® using the terms "skin neoplasms … In this study, 650 incident cases of melanoma in 1987-1989 were identified through the Connecticut Tumor … Good
No difference in the incidence of first cancers. … Sunscreen reduced the total incidence of squamous cell cancers but not basal cell cancers.
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007v2_MaskedStats_Core_Weighted.PDF
April 09, 2010 - 14: Cancer of colon 34,920 0.03
15: Cancer of rectum and anus 11,581 0.01
16: Cancer of liver and … ; other and unspecified primary 3,239 0.00
42: Secondary malignancies 131,834 0.11
43: Malignant neoplasm … without specification of site 4,842 0.00
44: Neoplasms of unspecified nature or uncertain behavior … 33,714 0.03
45: Maintenance chemotherapy; radiotherapy 4,468 0.00
46: Benign neoplasm of uterus 33,499 … 0.03
47: Other and unspecified benign neoplasm 53,592 0.04
48: Thyroid disorders 37,454 0.03
49:
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2008_MaskedStats_Core_Weighted.PDF
January 01, 2008 - 14: Cancer of colon 35,317 0.03
15: Cancer of rectum and anus 11,280 0.01
16: Cancer of liver and … ; other and unspecified primary 3,229 0.00
42: Secondary malignancies 129,333 0.10
43: Malignant neoplasm … without specification of site 6,063 0.00
44: Neoplasms of unspecified nature or uncertain behavior … 34,086 0.03
45: Maintenance chemotherapy; radiotherapy 4,289 0.00
46: Benign neoplasm of uterus 35,571 … 0.03
47: Other and unspecified benign neoplasm 53,605 0.04
48: Thyroid disorders 38,390 0.03
49:
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2007_MaskedStats_Core_Weighted.PDF
January 01, 2007 - 14: Cancer of colon 34,826 0.03
15: Cancer of rectum and anus 11,830 0.01
16: Cancer of liver and … ; other and unspecified primary 3,540 0.00
42: Secondary malignancies 129,279 0.11
43: Malignant neoplasm … without specification of site 4,722 0.00
44: Neoplasms of unspecified nature or uncertain behavior … 33,148 0.03
45: Maintenance chemotherapy; radiotherapy 5,281 0.00
46: Benign neoplasm of uterus 34,062 … 0.03
47: Other and unspecified benign neoplasm 54,805 0.04
48: Thyroid disorders 38,709 0.03
49:
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/cancer_older_adults.pdf
September 28, 2012 - KEY WORDS: older adults; cancer screening; patient preferences. … and prostate cancer decision making. … Breslau, PhD at the National Cancer
Institute, Dr. … Screening for Cervical Cancer:
Recommendations and Rationale. … Outcomes Assessment in Cancer: Measures, Methods, and Applications.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary12/cervical-cancer-screening-2012
October 18, 2011 - controlled trials (RCTs) (120,533 participants), primary HPV screening detected more cases of CIN grade 3 or cancers … Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV … Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial … neoplasia 3: a retrospective cohort study. … Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical
-
hcup-us.ahrq.gov/db/tools/HCUP_Formats.TXT
December 28, 2023 - diagnosis"
1 - 10 = " 1: Infectious and Parasitic DX"
11 - 47 = " 2: Neoplasms … ; other and unspecified primary"
42 = " 42: Secondary malignancies" … 43 = " 43: Malignant neoplasm without specification of site"
44 = " 44: Neoplasms … 45 = " 45: Maintenance chemotherapy; radiotherapy"
46 = " 46: Benign … neoplasm of uterus"
47 = " 47: Other and unspecified benign neoplasm"
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-breast-cancer/breast-cancer-screening-january-2016
January 11, 2016 - defined by stage and tumor size). … Committee on Cancer TNM system based on tumor size, lymph node involvement, and presence of metastasis … one study. 82 A randomized trial of annual versus triennial screening indicated detection of more tumors … Third, studies used heterogeneous definitions for advanced breast cancer that did not consider tumor … size >20 mm: 22% vs. 24%
OR (for 2-y interval vs. 1-y interval
Late stage for invasive cancers
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-6kN7TPcfEj2owG4GTN2jA
June 01, 2012 - cervix
and who do not have a history of a high-grade precancerous lesion
(cervical intraepithelial neoplasia … Efficacy of human papillomavirus testing for the detection of
invasive cervical cancers and cervical … intraepithelial neoplasia: a randomised con-
trolled trial. … Human papillomavirus DNA testing for the detection of cervical intra-
epithelial neoplasia grade 3 and … Human papillomavirus testing for the detection of high-grade
cervical intraepithelial neoplasia and cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
March 25, 2012 - “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR
carcinoma)) AND … OR ((ovarian OR breast OR colorectal
OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND
(‘neoplasm’/exp OR … ‘neoplasms’/exp OR ‘cancer’/exp OR ‘carcinoma’/exp)) AND
[humans]/lim AND [english]/lim AND [embase] … /lim
#60 #17 AND #59
#61 #56 AND #60
Ovarian Cancer
#61 ‘ovarian’/exp AND (‘neoplasm’/exp OR
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RkeQEwKRWULreuWecXG8S-
July 01, 2013 - compared with the stage-specific survival if the same tumor had been diagnosed clinically, later … curative treatment fails, the survival of the patient will equal the survival in the
case in which the tumor … Model F estimates cure rates that depend on sex, tumor
stage, and histology. … For detected cancers in Model U,
time to death from lung cancer is based on survival models that define … Model S estimates the probability of lethal metastases as a function of
tumor size, histology, and